ADVANCE infectious diseases pharmacy through collaboration, research and education and LEAD antimicrobial stewardship to OPTIMIZE the care of patients with infections in every practice setting

Featured News

  • 03 Dec 2018 10:14 AM | Anonymous member (Administrator)

    The Board of Pharmacy Specialties (BPS) is seeking board-certified pharmacists to serve on its Infectious Diseases, Cardiology, and Geriatric Pharmacy Specialty Councils for the 2019-2021 term.  Information on the purpose, eligibility, nomination materials, and desired characteristics may be found on the BPS website by accessing the following link.

    BPS must receive nominations materials before Monday, December 17th.

  • 05 Oct 2018 8:50 AM | Anonymous member (Administrator)

    We invite you to participate in a live CE webinar, Vancomycin Dosing: From Trough to AUC.  

    Thursday, October 18 at 12pm CT
    (10am PT, 11am MT, 1pm ET)

    Co-produced by ProCE and the Society of Infectious Diseases Pharmacists Education Center (SIDPEC)

    There are no fees for participating in this 1.0 contact hour CE activity.

    Learning Objectives
    The target audience for this activity includes pharmacists. After completing this activity, participants should be able to:
    • Discuss the data supporting an AUC-based dosing strategy for vancomycin.
    • Describe anticipated recommendations from the upcoming vancomycin guidelines.
    • Describe the different approaches and pros and cons for estimating vancomycin AUC exposures.
    • Outline key strategies to successful implementation of an AUC based dosing protocol.

    Michael J. Rybak, Pharm.D., M.P.H., Ph.D.
    Professor of Pharmacy & Medicine 
    Anti-Infective Research Laboratory
    Department of Pharmacy Practice 
    Eugene Applebaum College of Pharmacy & Health Sciences
    Wayne State University

    Jason M. Pogue, PharmD, BCPS AQ-ID
    Clinical Pharmacist, Infectious Diseases 
    Sinai-Grace Hospital; Detroit Medical Center
    Clinical Assistant Professor of Medicine
    Wayne State University School of Medicine


    Continuing Education Credit 

    ACPEThis activity is jointly provided by ProCE, Inc. and the Society of Infectious Diseases Pharmacists. ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-18-394-L01-P has been assigned to this live knowledge-based activity (initial release date 10-18-18). This activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Participants must complete the online post-test and activity evaluation within 30 days of the live activity to receive pharmacy CE credit. Statements of completion will be issued online at and proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.

    Click here for more information 


    Staff at ProCE
    ProCE, Inc. 
    Phone: 630.540.2848 · Fax 630.540.2849

  • 05 Sep 2018 10:13 AM | Anonymous member (Administrator)

    SIDP has signed on to support "Antibiotics Off the Menu", asking the six largest fast food companies to further the fight against antibiotic resistance and become antibiotic stewardship leaders by expanding their commitment to sourcing responsibly raised meats and implementing these commitments. Learn more here: 

  • 29 Aug 2018 12:35 PM | Anonymous member (Administrator)

    Dear Colleagues,   


    It is with great sadness that I share the news that Dr. Alan Forrest has passed away this weekend.  Alan was a mentor, colleague and friend to many in SIDP.  Brian Tsuji and others prepared the following summary of Alan’s career which I share with permission: 

    Alan was a wonderful friend, mentor, colleague and a true inspiration to our community and beyond.  He was a giant in the field of antimicrobial pharmacokinetics, pharmacodynamics and toxicodynamics (PK/PD/TD) as a researcher and educator for over 37 years. Alan started his career at the University of Southern California in Dr. Roger Jelliffe’s Laboratory and held a number of prestigious faculty positions at USC, the University of Maryland and the University at Buffalo. He served most recently as a Clinical Professor and Director of the Center for Pharmacometrics at the University of North Carolina. He also worked as the Senior Director of Pharmacometrics at the Institute for Clinical Pharmacodynamics and was an expert adviser to the Food and Drug Administration and the Pharmaceutical Industry.

    Alan made immeasurable contributions to the field of antimicrobial pharmacometrics. He was the leading scientist in the world on adaptive feedback control and individualizing therapy using PK/PD/TD systems analysis. He brought these advanced dosing algorithms all the way to clinical application for many of the antibiotics we use today. His pivotal paper on ciprofloxacin pharmacodynamics revolutionized antimicrobial drug development and has been cited >1,000 times. As a result of his work, exposure response analyses for antimicrobials have become standard practice in translational drug development.

     Alan had a tireless work ethic and was extremely driven. Although his days typically started at 7am and he mostly worked 7 days a week, he was always so generous with his time for others. He was a selfless and extremely dedicated mentor and friend to over 100 trainees all over the world. Alan was also a brilliant presenter and explained complex mathematical models with elegance. In 2016, he was honored with the Lewis B. Sheiner Lecture Award at the American Conference on Pharmacometrics. Throughout his esteemed career Alan always maintained his focus in translating his research into clinical practice to improve the care of patients.


    He will be dearly missed by all of us.  

    Those wishing may make donations to the Eshelman School of Pharmacy or to the National Kidney Foundation at  A family guestbook is available at

    Libby Dodds Ashley

    President, SIDP

  • 21 Aug 2018 12:31 PM | Anonymous member (Administrator)

    The Young Investigator Research Award (YIRA) proposal deadline has been extended to September 7th. Both the YIRA and The Ocean Spray Prevention of Urinary Tract Infections Research Award proposals must be submitted by email no later than 5 PM E.S.T. on September 7, 2018.  Proposals should be converted to a single PDF file and electronically submitted to both Elizabeth Schumacher, Executive Director ( and the Chair of the Research Committee, Warren Rose ( Please see previous communications and the RFPs for further instructions. Applications submitted after the application deadline will not be considered.

  • 10 Aug 2018 11:29 AM | Anonymous member (Administrator)

    SIDP board member Dr. Susan Davis talks with Dr. Paul Sax on the critical role of the Infectious Diseases Pharmacist in improving patient outcomes.

    Check out this podcast published by Oxford University Press on behalf of Infectious Diseases Society of AmericaClick here to either download the podcast discussion or read the transcript of the conversation.

  • 07 Aug 2018 11:48 AM | Anonymous member (Administrator)

    The Board of Directors of the Society of Infectious Diseases Pharmacists (SIDP) is pleased to announce the funding of research proposal for The Ocean Spray Prevention of Urinary Tract Infections Research Award.

    Proposal should follow the guidelines described in the RFP (download here).

    Submission of RFP:

    Proposals should be converted to a single PDF file adhering to the format described above. The PDF file should be electronically submitted to both Elizabeth Schumacher, Executive Director ( and the Chair of the Research Committee, Warren Rose ( Proposals must be submitted by online by email no later than 5 PM E.S.T. on September 7, 2018. Applications submitted after the application deadline, will not be considered. 

  • 02 Aug 2018 4:13 PM | Anonymous member (Administrator)
    The Board of Directors of the Society of Infectious Diseases Pharmacists (SIDP) is pleased to announce the availability of funding for an Infectious Diseases Pharmacotherapy Residency for the period of July 2019 through June 2020. This residency award will be partially supported by BioMerieux and Allergan Inc.

    Proposal should follow the guidelines described in the RFP (download here).

    Completed applications should be electronically submitted as follows:

    Applications should be entered online at the SIDP website ( using the resident award application form.  The RPD cover letter, letters of support (2) and curriculum vitas (up to 4) should be converted to a single PDF file and uploaded. Other information will be directly inserted on the web form.  Questions regarding submission may be submitted to SIDP Secretary/Treasurer, Emily Heil, PharmD ( Proposals must be submitted no later than 5 PM EST on September 7, 2018. Applications submitted after this deadline will not be considered.  The Board of Directors will make decisions on the applications no later than September 30, 2018.

  • 26 Jul 2018 8:50 AM | Anonymous member (Administrator)

    SIDP is pleased to join over 30 organizations in expressing support for congress to approve the Re-Valuing Antimicrobial Products (REVAMP) Act. This act aims to de-link incentives for the development of priority antimicrobials from the bulk number of sales or amount administered of those agents. In short, the REVAMP Act would develop a process where a company who brings a new priority antimicrobial to market may transfer up to 12 months of exclusivity to another product in order to provide financial incentive for antimicrobial development. The REVAMP Act would also require the sponsor to ensure proper stewardship of the novel antimicrobial agent as part of the agreement. SIDP applauds this novel approach to ensure both the continued development of new antimicrobials for life threatening drug-resistant infections as well as responsible stewardship of these agents.

    Read the statement of support here.

    Click here to read either a summary or the full REVAMP act.

  • 25 Jul 2018 4:29 PM | Anonymous member (Administrator)
    SIDP is pleased to announce the availability of a new tool to support stewardship efforts in the post-acute and long-term care setting.  The National Quality Partners™Playbook: Antibiotic Stewardship in Post-Acute and Long-Term Care was written with input from more than 50 key experts, including current SIDP President Dr. Elizabeth Dodds Ashley and Secretary/Treasurer Dr. Emily Heil.  The playbook offers practical strategies and useful resources for implementing high-quality antibiotic stewardship programs in post-acute and long-term care facilities. For access to this and other NQF materials, enter the SIDP members store on the NQF website here. As an SIDP member, you will receive the NQF Member rate – including a 50% discount off the usual list price for this valuable tool. 


Membership gives you more

  • Access exclusive opportunities
  • Connect with colleagues
  • Attend networking events


Society of Infectious Diseases Pharmacists • 403 W. Saint Charles, Suite B, Lombard, IL 60148
(331) 248-7888
Proudly Managed by Affinity Strategies

Powered by Wild Apricot Membership Software